ArticleCommunications chemistry2025
Synthesis of Acinetobacter baumannii Lipid A(s) and derivatives and their structure-immunostimulatory activity relationships.
Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phage Therapy forAntibiotics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acinetobacter baumannii emerges as one of the most worrisome pathogens causing a majority of hospital-acquired infections worldwide. However, the knowledge of its virulence factors remains obscure, in particular the bacterial lipooligosaccharides (LOS). Lipid A of the bacterial LOS exists as an inseparable mixture of homologues, making it impossible to study the immunological activity of each component. We herein report the synthesis of A. baumannii lipid A(s) (1-4) and corresponding monophosphate derivatives (1', 3' and 4'). The synthetic scheme features a short and stereoselective preparation of β-hydroxy acids and a convergent assembly of lipid A species with diverse structures. Subsequent immunological studies indicate that A. baumannii lipid A (2) having a [4 + 2]-acylation pattern displays the highest stimulatory potency. Further computational studies suggest that 2 and E. coli lipid A (5) sharing the same acylation pattern adopt an inverted binding mode in the TLR4/MD-2 receptor complex.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.